Structure Therapeutics (GPCR) is stepping into the spotlight as it prepares to release topline data from its ACCESS trial of aleniglipron, an oral GLP 1 candidate for obesity, along with a same day ...
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Complex fluids, such as polymer melts and concentrated suspensions, are foundational materials for industrial products, ...
Microsoft announced on Monday that it will soon block mobile devices running outdated email software from accessing Exchange Online services until they're updated. As the Exchange Team explained, ...
Tech Xplore on MSN
One pull of a string is all it takes to deploy these complex structures
MIT researchers have developed a new method for designing 3D structures that can be transformed from a flat configuration ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
Semi-liquid funds have emerged in the expanding Private Credit market, addressing investor concerns about liquidity and re-investment risks.(Vivriti Asset Management) The Private Credit market has ...
House Democrats again released a folder of images from the estate of Jeffrey Epstein, publishing dozens of previously unreleased photographs and documents on Thursday as part of an ongoing review tied ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback